Platelet Function Analysis (PFA)
Platelet Function Evaluation, Platelet Function Screen , Antrim #26245, EPIC: LAB5200, SOFT: PFA
This test is available only to patients drawn on the Grosse Pointe, Royal Oak, and Troy Hospital campuses.
Specimen Collection Criteria
Collect: Two Light Blue-top Becton-Dickinson 3.2% Sodium Citrate tubes.
- TUBES MUST BE FULL.
- Venipuncture should be performed using a 21G or larger needle (20G or 19G). Use of a butterfly collection device is not recommended.
- Tubes must be HAND-DELIVERED to the Coagulation Laboratory immediately. Do NOT send through the pneumatic tube system.
Preparation for Courier Transport
Transport: Whole blood at room temperature (20-26°C or 68-78.8°F).
- Specimens collected in Serum Separator (SST) or Heparin tubes.
- Specimens collected at sites other than Grosse Pointe, Royal Oak and Troy Hospital campuses.
- Glass tubes and 3.8% Sodium Citrate tubes.
- Specimens that are clotted or grossly hemolyzed.
- Inappropriate specimen volume.
- Specimens received in the Laboratory more than 1 hour past the time of collection.
1,Specimens must be kept at room temperature (20o
to 26o C; 68o to 79o F) and analyzed within
hours of collection. Specimens must arrive in the coagulation
lab within 1 hour of the draw.
Sunday - Saturday, 24 hours a day.
Results available within 3 hours of receipt in the Laboratory.
Collagen/Epinephrine: Less than or equal to 160 seconds.
Collagen/ADP: Less than or equal to 106 seconds.
Children greater than two years of age have been reported to have closure times similar to adults.
Artificial Wound Model which measures Closure Time (Siemens PFA-100 Analyzer).
The end point of the assay is closure time. Prolongation of closure times with both ADP and Epi cartridges indicates a defect in platelet function or Von Willebrand Disease (VWD) . Prolongation of the Coll-Epi closure time with normal or near normal Coll-ADP closure time is characteristic of aspirin. Ticlopidine (Ticlid) and clopidogrel (Plavix) without concurrent apsirin do not affect the PFA-100.
A normal PFA-100 result does not completely exclude platelet dyfunction as it lacks sensitivity to some congenital defects and anti-platelet drugs. If there is substansive bleeding history or further clinical suspicion of a bleeding disorder, consider platelet aggregation studies for further evaluation. Platelet aggregation studies can be arranged by calling the Appointment Center.
- Microthrombi in the sample or particulates introduced into the sample from the environment could adversely affect the test results.
- The medication history of the patient should be reviewed as many medications are known to affect platelet function.
- Results will be affected by low hematocrits (less than 35) or decreased platelet counts (less than 150,000).
- Certain fatty acids and lipids found in various human diets are known to inhibit platelet function. Physicians may wish to advise patients to refrain from fatty foods prior to testing.
- Hemolyzed specimens may interfere with this assay by reduction in hematocrit or the release of ADP.
This assay provides an indication of platelet function. This assay is a screening test for platelet function defects, von Willebrand disease, and aspirin-induced platelet dysfunction. Results should be evaluated in conjunction with clinical history and other laboratory findings (e.g. platelet aggregation).
Antrim #26245, EPIC: LAB5200, SOFT: PFA
Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.
This directory currently reflects information only for specimens collected and/or processed at the
Farmington Hills, Grosse Pointe, Royal Oak, and Troy campuses.